RavenQuest BioMed: Unique, Two-Pronged Business Model Diversifies Risk -- CFN Media

Seattle, Washington--(Newsfile Corp. - December 12, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing RavenQuest BioMed Inc. (CSE: RQB) and its dual approach to the legal cannabis industry which diversifies the company's risk. The Canadian cannabis industry is projected to reach $22.6 billion over the coming years (Deloitte) driven by the legalization of adult-use cannabis next year.

Consulting & Management Services

RavenQuest Technologies Inc. is focused on consulting and management services. After helping more than ten companies secure licenses, the company has become a leading end-to-end solution provider to both late-stage applicants and existing licensed producers. It is instrumental in helping clients design and build facilities, while incorporating proprietary, industry-leading growing and drying technologies.

Management believes that the industry is undergoing an important transition from 'basement growing' to highly-specialized operations. The company's automated Orbital Garden 2.0 is a revolutionary innovation that enables the production of large quantities of cannabis in smaller areas by maximizing the productivity of grow space and lighting. With total production of over 300 grams per square foot, the technology more than doubles industry averages.

In addition to production benefits, the Orbital Garden 2.0 scales to hundreds of automated growing systems with remote monitoring and control of nutrient levels, acidity, CO2, water levels, water temperature, and more. The technology provides a 70% to 80% reduction in electrical costs and a 25% reduction in nutrient costs, which helps licensed producers dramatically improve their profit margins and ensure top quality product.

In addition to its innovative technologies, the company's management team has developed relationships with indigenous peoples. The team recently announced a contract to build a 24,000 square foot facility for Fort McMurray Nation and, through its many existing relationships, plans to offer similar turnkey solutions to Indigenous populations across the country. These solutions will handle everything from securing the proper zoning to facility design to navigating the application process.

Investments and Research

RQB Capital Corp. is an investment wing focused on investing and acquiring licensed producers. The division recently acquired Alberta Green Biotech, which has a 35,500 sq. ft. production facility under construction. The facility will produce about 7,000 kilograms of cannabis per year once operational in mid- to late- next year, making it one of the industry's leading grams per square foot cultivation facilities.

Aside from these investments, the company announced a landmark research agreement with top-ranked McGill University that paves the way for collaboration between two laboratories. The research will seek to prove out the science surrounding cultivar recognition, yield enhancement, and plant stabilization, all areas with limited industry knowledge due to cannabis' long-time classification as a controlled substance. The research could generate tremendous long-term value in the form of a plant breeders rights or through the development of new and innovative technologies for its portfolio.

These two areas of long-term focus provide investors with potentially significant capital gains opportunities over time compared to the consulting division, which focuses upon generating near-term operational revenue.

Looking Ahead

RavenQuest BioMed Inc. (CSE: RQB) has taken a unique, diversified approach which generates immediate revenue from its services division (which limits cash burn normally associated with early stage cannabis companies) and simultaneously invests in near-term licensed producers like Alberta Green Biotech. At the same time, it has leveraged its relationships with indigenous peoples to open the door to larger projects and invested in R&D initiatives through a partnership with McGill University.

Please follow the link to read the full article: http://www.cannabisfn.com/ravenquest-biomed-unique-two-pronged-business-model-diversifies-risk/

For more information, visit the company's website or download their investor presentation.

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/

Contact

CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com